Part-Time Clinical Research Coordinator - Valencia

KCR Placement; Madrid; On-site; EUR 32,000 - 42,000; Part time

Benefits offered by this job

Annual leave entitlements

Health insurance offerings

Retirement planning offerings

Employee Assistance Programme

Job summary

ICON plc is seeking a Clinical Research Coordinator (50% FTE) in Valencia, Spain. You will coordinate day-to-day activities of clinical trials, ensuring execution and compliance with study protocols and regulatory standards.

You will manage trial logistics, support site staff, monitor progress, and maintain high data quality while upholding GCP guidelines and patient safety throughout the trial lifecycle.

Qualifications

• Bachelor's degree in a relevant scientific discipline or healthcare-related field.
• Extensive experience as a Clinical Research Coordinator with understanding of trial processes and regulatory requirements.
• Strong organizational and multitasking skills to manage multiple trial aspects.

Responsibilities

• Coordinate and manage the operational aspects of clinical trials, including participant recruitment, scheduling, and site logistics.
• Ensure adherence to study protocols, regulatory requirements, and GCP standards.
• Monitor and document trial progress, including data collection, safety reporting, and regulatory compliance.
• Provide training and support to site staff to ensure effective execution of trial procedures and protocols.
• Build and maintain relationships with study participants and site personnel to facilitate smooth trial operations.

Skills

Excellent communication

Organization & multitasking

Attention to data management

Team collaboration

Education

Bachelor's degree in a relevant scientific discipline

Job description

ICON plc is seeking a Clinical Research Coordinator (50% FTE) in Valencia, Spain. You will coordinate day-to-day activities of clinical trials, ensuring execution and compliance with study protocols and regulatory standards.

You will manage trial logistics, support site staff, monitor progress, and maintain high data quality while upholding GCP guidelines and patient safety throughout the trial lifecycle.